HomeNVO • NYSE
add
Novo Nordisk A/S
Previous close
$136.88
Day range
$135.92 - $137.15
Year range
$86.96 - $148.15
Market cap
467.04B USD
Avg Volume
4.42M
In the news
Financials
Income Statement
Revenue
Net income
(DKK) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 68.06B | 25.34% |
Operating expense | 26.15B | 15.94% |
Net income | 20.05B | 3.20% |
Net profit margin | 29.46 | -17.66% |
Earnings per share | 4.49 | 4.06% |
EBITDA | 34.78B | 33.43% |
Effective tax rate | 20.85% | — |
Balance Sheet
Total assets
Total liabilities
(DKK) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 62.65B | 72.09% |
Total assets | 369.38B | 31.57% |
Total liabilities | 256.86B | 34.99% |
Total equity | 112.52B | — |
Shares outstanding | 4.46B | — |
Price to book | 5.42 | — |
Return on assets | 23.67% | — |
Return on capital | 53.54% | — |
Cash Flow
Net change in cash
(DKK) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 20.05B | 3.20% |
Cash from operations | 50.50B | 76.73% |
Cash from investing | -20.73B | -123.27% |
Cash from financing | 16.68B | 232.52% |
Net change in cash | 46.50B | 600.47% |
Free cash flow | 28.97B | 96.77% |
About
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd with production facilities in nine countries and affiliates or offices in five countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority of its voting shares.
Novo Nordisk manufactures and markets pharmaceutical products and services, specifically diabetes care medications and devices. Its main product is the drug semaglutide, used to treat diabetes under the brand names Ozempic and Rybelsus and obesity under the brand name Wegovy. Novo Nordisk is also involved with hemostasis management, growth hormone therapy, and hormone replacement therapy. The company makes several drugs under various brand names, including Levemir, Tresiba, NovoLog, Novolin R, NovoSeven, NovoEight, and Victoza.
Novo Nordisk employs more than 48,000 people globally, and markets its products in 168 countries. The corporation was created in 1989, through a merger of two Danish companies, which date back to the 1920s. The Novo Nordisk logo is the Apis bull, one of the sacred animals of ancient Egypt, denoted by the hieroglyph 𓃒. Wikipedia
Founded
Dec 21, 1923
Headquarters
Website
Employees
69,260